[Federal Register Volume 76, Number 45 (Tuesday, March 8, 2011)]
[Page 12740]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-5157]



Centers for Disease Control and Prevention

[Docket Number NIOSH-227]

Request for Information on Conditions Relating to Cancer to 
Consider for the World Trade Center Health Program

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice and request for public comments.


SUMMARY: The Director of the National Institute for Occupational Safety 
and Health (NIOSH) of the Centers for Disease Control and Prevention 
(CDC) serves as the World Trade Center (WTC) Program Administrator for 
certain functions related to the WTC Health Program established by the 
James Zadroga 9/11 Health and Compensation Act (Pub. L. 111-347). In 
accordance with Section 3312(a)(5)(A) of that Act, the WTC Program 
Administrator is conducting a review of all available scientific and 
medical evidence to determine if, based on the scientific evidence, 
cancer or a certain type of cancer should be added to the applicable 
list of health conditions covered by the World Trade Center Health 
    The WTC Program Administrator is requesting information on the 
following: (1) Relevant reports, publications, and case information of 
scientific and medical findings where exposure to airborne toxins, any 
other hazard, or any other adverse condition resulting from the 
September 11, 2001 terrorist attacks, is substantially likely to be a 
significant factor in aggravating, contributing to, or causing cancer 
or a type of cancer; (2) clinical findings from the Clinical Centers of 
Excellence providing monitoring and treatment services to WTC 
responders (i.e., those persons who performed rescue, recovery, clean-
up and remediation work on the WTC disaster sites) and community 
members directly exposed to the dust cloud on 9/11/01; and (3) input on 
the scientific criteria to be used by experts to evaluate the weight of 
the medical and scientific evidence regarding such potential health 

DATES: Comments must be received by March 31, 2011.

ADDRESSES: You may submit comments, identified by docket number NIOSH-
227, by any of the following methods:
     Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 
MS-C34, 4676 Columbia Parkway, Cincinnati, OH 45226.
     Facsimile: (513) 533-8285.
     E-mail: [email protected].
    All information received in response to this notice will be 
available for public examination and copying at the NIOSH Docket 
Office, 4676 Columbia Parkway, Cincinnati, Ohio 45226. The comment 
period for NIOSH-227 will close on March 31, 2011. All comments 
received will be available on the NIOSH Docket Web page at http://www.cdc.gov/niosh/docket by April 30, and comments will be available in 
writing by request. NIOSH includes all comments received without change 
in the docket and the electronic docket, including any personal 
information provided.

Plaza Suite 9200, 395 E St., SW., Washington, DC 20201, telephone (202) 
245-0625 or e-mail [email protected].

John Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2011-5157 Filed 3-7-11; 8:45 am]